https://www.selleckchem.com/pr....oducts/fluorofurimaz
Spinal ganglioneuroma (GN) is the most benign neoplasm of neuroblastic origin. There is little knowledge about spinal GN because of sporadic cases reported. The objective of this study is to describe the clinical manifestations and long-term follow-up outcomes of spinal GN after consecutive treatment. The clinical and follow-up data of 31 patients with spinal GN receiving consecutive treatment in our institute are retrospectively analyzed. The mean age of the 31 patients was 40.39 ± 14.8years. They were diagnosed with spinal GN